Skip to main content
Clinical Trials/NCT03890107
NCT03890107
Completed
Not Applicable

Clinical Evaluation of a New Middle Ear Diagnostic to Support FDA Regulatory Clearance

PhotoniCare, Inc.2 sites in 1 country110 target enrollmentApril 15, 2019
ConditionsOtitis Media

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Otitis Media
Sponsor
PhotoniCare, Inc.
Enrollment
110
Locations
2
Primary Endpoint
OtoSight imaging exam
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this study is to evaluate the imaging capabilities and image analysis performance of the OtoSight Middle Ear Scope in pediatric patients undergoing tympanostomy tube placement for otitis media. In this observational study, results of OtoSight imaging will not affect patient standard of care.

Registry
clinicaltrials.gov
Start Date
April 15, 2019
End Date
April 30, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children (17 years old or younger) scheduled for tympanostomy tube placement

Exclusion Criteria

  • Otoscopy contra-indicated or not possible per attending physician's decision

Outcomes

Primary Outcomes

OtoSight imaging exam

Time Frame: 1-5 minutes

Optical coherence tomography imaging to evaluate the middle ear.

Secondary Outcomes

  • Adverse events(Date of recruitment (day of surgery) to post-operative follow-up visit (approx. 1 month, but can be longer))

Study Sites (2)

Loading locations...

Similar Trials